| P2093 | author name string | Jan C Buckner | |
| P2860 | cites work | Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. | Q30275188 |
| | International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors | Q30426724 |
| | Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma | Q30661157 |
| | Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma | Q33710967 |
| | Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. | Q34446549 |
| | Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma | Q37518265 |
| | Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. | Q37613957 |
| P433 | issue | 2 | |
| P304 | page(s) | 145-146 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Adjuvant nitrosoureas: will they ever go away? | |
| P478 | volume | 19 | |